UPDATE: Citigroup Upgrades Regeneron Pharmaceuticals By: Benzinga via Benzinga March 17, 2014 at 10:02 AM EDT On Monday, Citigroup upgraded shares of Regeneron (NASDAQ: REGN) from Neutral to Buy and raised the price target from $342 to $390. ... Read More >> Related Stocks: Regeneron Pharmaceuticals